REALLY, revenue up 66%, expenses up 41%, loss after tax up 27% to $9M.
They are not getting traction with KP. It’s been over a year that they have been trying to interstate. They may have a great product with clinical utility but with the first bulk order customer they can’t Integrate systems for ordering and processes?
a really disappointing result. The SP has take. A hammering as a result. The only good thing is that they won’t need to raise funds for a while.
the sales force needs to get traction otherwise why are we paying them. It would seem to me that covid is causing issues generally - sure we can do in home testing, but if people aren’t going out to the doctor it’s irrelevant.
REALLY, revenue up 66%, expenses up 41%, loss after tax up 27%...
Add to My Watchlist
What is My Watchlist?
